Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates

Glaukos (GKOS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.4 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -26.47%. A quarter ago, it was expected that this glaucoma treatments developer would post a loss of $0.27 per share when it actually produced a loss of $0.16, delivering a surprise of +40.74%.Over the last four quarters, the com ...